Sign in

Lost your password?
(close)

France

France / Germany Production Alliance Falters; Sanofi Vaccine Enters Phase III Trials; Valneva Still in the Vaccine Race

The latest news from French pharma, including why President Emmanuel Macron’s initiative to bring medical production back to Europe has hit a wall, Sanofi’s slow progress towards finally bringing its…

France / ‘Humiliation’ & the Sanofi-Pfizer Vaccine Deal; AntiVax Struggles; Servier’s Neurology Push

The latest from French pharma where Sanofi has inked a deal to produce 125 million doses of Pfizer’s COVID-19…

COVID-19 Vaccines / Valneva: A Success Story for France?

While Big Pharma companies like Pfizer, Janssen and AstraZeneca, have grabbed the headlines over the past year for…

France / Mid-2021 for Sanofi COVID-19 Vaccine; 1 Million Domestic Cases; Ipsen Growth

A roundup of the latest stories from French pharma, including the progress of Sanofi’s COVID-19 vaccine, how…

In Conversation

Newly Independent CDMO Skyepharma Looks to Expansion

Fresh from a management buyout and the establishment of Skyepharma as an independent company, Managing Director David Lescuyer charts the fully integrated French CDMO’s startling growth trajectory over the past five years and outlines how the firm is well positioned for further growth. Lescuyer also highlights some of the key trends in the CDMO marketplace today, including the crucial importance…

Newly Independent CDMO Skyepharma Looks to Expansion

Newly Independent CDMO Skyepharma Looks to Expansion

News Roundup / French Pharma August 2020

A roundup of some of the latest from French pharma, including Sanofi’s bumper Prinicipia deal, how Unither’s…

Development & Manufacturing / Newly Independent CDMO Skyepharma Looks to Expansion

Fresh from a management buyout and the establishment of Skyepharma as an independent company, Managing Director…

Sanofi / Thomas Triomphe Appointed Executive Vice President of Vaccines Unit

With former head David Loew moving to the CEO position at Ipsen, Sanofi appointed French national Thomas Triomphe…

Mid-Cap Strategies / LFB USA CEO Optimistic on Hemophilia Launches Amid COVID Crisis

French firm LFB is targeting the lucrative US market with its hemophilia products and recently received two FDA…

Sanofi / USD 679 Million Investment in French Vaccine Manufacturing

French pharma giant Sanofi is pivoting its focus to invest more heavily in vaccines with a plan to invest USD 679…

We use cookies to ensure that we give you the best experience on our site. For more info click here